DK144035B - ANALOGY PROCEDURE FOR PREPARING 2- (THIENYL-3-AMINO) -1,3-DIAZACYCLOPENTENES - Google Patents

ANALOGY PROCEDURE FOR PREPARING 2- (THIENYL-3-AMINO) -1,3-DIAZACYCLOPENTENES Download PDF

Info

Publication number
DK144035B
DK144035B DK419670A DK419670A DK144035B DK 144035 B DK144035 B DK 144035B DK 419670 A DK419670 A DK 419670A DK 419670 A DK419670 A DK 419670A DK 144035 B DK144035 B DK 144035B
Authority
DK
Denmark
Prior art keywords
amino
formula
thienyl
methylthienyl
hydrochloride
Prior art date
Application number
DK419670A
Other languages
Danish (da)
Other versions
DK144035C (en
Inventor
R Rippel
H Ruschig
E Lindner
M Schorr
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19691941761 external-priority patent/DE1941761C3/en
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK144035B publication Critical patent/DK144035B/en
Application granted granted Critical
Publication of DK144035C publication Critical patent/DK144035C/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Description

i 14/1035 oi 14/1035 o

Opfindelsen angår en analogifremgangsmåde til fremstilling af hidtil ukendte 2-(thienyl-3'-amino)-1,3--diazacyclopentener med den almene formel o viN-CHR4This invention relates to an analogous process for the preparation of novel 2- (thienyl-3'-amino) -1,3-diazacyclopentenes of the general formula o-N-CHR 4

5 R2-,-rm-C I5 R2 -, - rm-C I

R3j[l.Rl Nft-CH2 1 2 7 hyor R , R og R betyder hydrogen, methyl, chlor, brom 4 eller iod, og R betyder hydrogen eller methyl, eller syre-10 additionssalte deraf med fysiologisk acceptable syrer.R3j [1.Rl Nft-CH2 1 2 7 hyor R, R and R means hydrogen, methyl, chloro, bromo 4 or iodo, and R means hydrogen or methyl, or acid addition salts thereof with physiologically acceptable acids.

Analogifremgangsmåden ifølge opfindelsen er ejendommelig ved, at a) thienyl-3-isothiuroniumsalte, -thiourinstoffer, -guanidiner, -nitroguanidiner eller -cyanamider med formel IX, 15 R2-,-f-NH-R (IX) o 20 hvor R betyder grupperne , HX (a), 25The analogous process of the invention is characterized in that a) thienyl-3-isothiuronium salts, thioureas, guanidines, nitroguanidines or cyanamides of formula IX, R , HX (a), 25

.S.S

-c^ (to),-c ^ (to),

^ NH^ NH

(c), 35 -C^T (d)i ^^NHNOg eller -CN (e), U4036(c), -C ^ T (d) in NH NHNOg or -CN (e), U

OISLAND

22

R~* betyder lavmolekylært alkyl, og X betyder· en syreanion, fortrinsvis en halogenidion, omsættes med alkylendiaminer med formel IIIR ~ represents low molecular alkyl and X represents an acid anion, preferably a halide ion, reacted with alkylene diamines of formula III

5 h2n-chr4-ch2-nh2 (III) 4 hvori R har ovennævnte betydning, eventuelt i form af disses monosalte, eller b) N- (3'-thienyl) -Ν'-aminoalkyl-(thio) urinstoffer ]_g med formel IV, R2-_-NH-C-NH-CHR4-CH0-NH0 i i it 2 2 R3- JJ-R1 A (IV) 15 1 4 hvor R-R har ovennævnte betydning, og A betyder et oxygeneller svovlatom lukkes til ring, ellerWherein R is as defined above, optionally in the form of their monosalts, or b) N- (3'-thienyl) -Ν'-aminoalkyl (thio) urea] g of formula IV, R 2

c) aminothiophener med formel Vc) aminothiophenes of formula V

20 r2-,-r-NH? R3 I LrI2 (V)20 r 2 -, - r-NH? R3 I LrI2 (V)

R_vns> RR_vns> R

1 3 hvori R -R har ovennævnte betydning, omsættes med 2-alkyl-25 mercapto-l,3-diazacyclopentener med formel VI, Æ-CHR4 R5-S-C i (VI)13 wherein R -R is as defined above, is reacted with 2-alkyl mercapto-1,3-diazacyclopentenes of formula VI, A-CHR 4 R 5 -S-C in (VI)

\NH_CH\ NH_CH

4 5 hvori R og R har ovennævnte betydning, fortrinsvis 3Q i form af disses salte, eller d) aminothiophener med formel V omsættes med bis-(2-oxo-l,3-diaza-cyclopentyl)-phosphinchlorider med formel VII, CHR —CH„ „ CHR— CH_ I I 2 S I I 2 35 HN N-P-*N NH (VII) \c/' ' \ c/ n Cl „ o o 144036 4 3Wherein R and R are as defined above, preferably 3Q in the form of their salts, or d) aminothiophenes of formula V are reacted with bis- (2-oxo-1,3-diaza-cyclopentyl) -phosphine chlorides of formula VII, CHR - CH "CHR - CH_ II 2 SII 2 35 HN NP- * N NH (VII) \ c / '' \ c / n Cl" oo 144036 4 3

OISLAND

hvori R har den ovennævnte betydning, eller e) thiophen-3-isocyanid-dihalogenider med formel VIII, 2 al 5 R-._ -N=C _ s | - \Hal r3-(^ (VIII) 1 3 hvor R —R har ovennævnte betydning, og Hal betyder et 10 chlor- eller bromatom, omsættes med alkylendlaminer med formel III, og at dannede forbindelser, i hvilke 12 3 mindst en af grupperne R , R eller R betyder et hydrogenatom, om ønsket halogeneres, hvorefter om ønsket de frem-15 stillede forbindelser ved hjælp af fysiologisk acceptable syrer omdannes til syreadditionssalte.wherein R is as defined above, or e) thiophene-3-isocyanide dihalides of formula VIII, 2aL 5 R -._ -N = C _ s | - \ Hal r3 - (^ (VIII) 13 where R - R is as defined above and Hal represents a chlorine or bromine atom, reacted with alkylendlamines of formula III and to form compounds in which at least one of the groups R, R, or R represent a hydrogen atom, if desired, to be halogenated and then, if desired, the compounds prepared by physiologically acceptable acids are converted into acid addition salts.

a) Fremstilingen af forbindelserne med formel I efter fremgangsmåde a) kan gennemføres ved simpel opvarmning (1/2-3 timer) af isothiuroniumsaltene med formel Ila 20 med alkylendiaminer med formel III til temperaturer mellem 80 og 200°C. Reaktionen kan dog også udføres i nærværelse af et opløsningsmiddel ved temperaturer mellem 60 og 140°C.a) The preparation of the compounds of formula I according to process a) can be carried out by simply heating (1 / 2-3 hours) of the isothiuronium salts of formula Ila 20 with alkylene diamines of formula III to temperatures between 80 and 200 ° C. However, the reaction can also be carried out in the presence of a solvent at temperatures between 60 and 140 ° C.

Som opløsningsmiddel kan især anvendes sådanne, som indeholder polære grupper, f.eks. vand eller lave alkoholer, 25 såsom methanol, ethanol, n- og iso-propanol. Ganske vist må der i nærværelse af et opløsningsmiddel opvarmes i længere tid (5-20 timer), og der må fortrinsvis arbejdes under tryk. I begge tilfælde er det hensigtsmæssigt at anvende et overskud (110-150%) af alkylendiamin.In particular, solvents containing polar groups, e.g. water or low alcohols such as methanol, ethanol, n- and isopropanol. Admittedly, in the presence of a solvent, it must be heated for an extended period (5-20 hours) and preferably pressurized. In both cases, it is appropriate to use an excess (110-150%) of alkylenediamine.

30 Isothiuroniumsaltene med formel II a fremstilles på kendt måde ved opvarmning af de tilsvarende thiourinstoffer med formel II b sammen med et lavt alkylhalogenid eller et dial-kylsulfat i et opløsningsmiddel, f.eks. en lav alkohol. Thio-urinstofferne kan ligeledes fremstilles efter i litteraturen 35 kendte fremgangsmåder (se: Houben-Weyl, bind 9, side 887 ff.) ud fra de tilsvarende substituerede aminothiophener.The isothiuronium salts of formula IIa are prepared in known manner by heating the corresponding thioureas of formula IIb together with a low alkyl halide or dialkyl sulfate in a solvent, e.g. a low alcohol. The thioureas can also be prepared according to methods known in the literature (see: Houben-Weyl, Vol. 9, page 887 et seq.) From the corresponding substituted aminothiophenes.

I stedet for thiuroniumsaltene kan man også direkte opvarme thiourinstofferne med formel Ilb sammen med alkylen-diaminerne med den almene formel III, fortrinsvis i vakuum, 4 0 144035 til temperaturer mellem 100 og 200°C. Herved anvendes ligeledes fortrinsvis et overskud af alkylendiamin.Instead of the thiuronium salts, one can also directly heat the thioureas of formula IIb together with the alkylene diamines of the general formula III, preferably in vacuo, to temperatures between 100 and 200 ° C. Preferably, an excess of alkylenediamine is also used.

De omhandlede forbindelser kan også tilvejebringes ved indvirkning af alkylen-diaminer med den almene formel III 5 eller disses monosalte på thienyl-3-guanidiner med formelThe compounds of the invention may also be provided by the action of alkylene diamines of general formula III or their monosalts on thienyl-3-guanidines of formula

Ile eller disses salte med uorganiske eller organiske syrer. Også herved kan omsætningen gennemføres såvel med som uden opløsningsmidler. De nødvendige temperaturer ligger mellem 100 og 200°C, fortrinsvis mellem 130 og 150°C. Som opløsnings-10 middel anvendes højere alkoholer, nitrobenzen osv. Eksempler på uorganiske salte er hydrochlorider, hydrobromider, hydro-iodider, sulfater og nitrater, til de organiske salte er benzen- eller toluensulfonater egnede.Ile or their salts with inorganic or organic acids. Also, the reaction can be carried out both with and without solvents. The required temperatures are between 100 and 200 ° C, preferably between 130 and 150 ° C. As the solvent, higher alcohols, nitrobenzene, etc. are used. Examples of inorganic salts are hydrochlorides, hydrobromides, hydroiodides, sulphates and nitrates, to which the organic salts are benzene or toluene sulphonates.

I stedet for thienyl-3-guanidiner kan man også 15 anvende de tilsvarende nitroguanidiner med formlen Ild som udgangsstoffer og opvarme dem med alkylendiaminer med den almene formel III i egnede opløsningsmidler, f.eks. ethanol, propanol, butanol eller amylalkohol. Udgangsprodukterne kan tilvejebringes ved omsætning af en tilsvarende amino-20 thiophen med N-methyl-N-nitroso-N'-nitroguanidin efterInstead of thienyl-3-guanidines, the corresponding nitroguanidines of formula Ild can also be used as starting materials and heat them with alkylene diamines of general formula III in suitable solvents, e.g. ethanol, propanol, butanol or amyl alcohol. The starting products can be obtained by reacting a corresponding amino-thiophene with N-methyl-N-nitroso-N'-nitroguanidine after

Journal of the American Chemical Society J59, 3028 (1947).Journal of the American Chemical Society J59, 3028 (1947).

Omsætningen af thienyl-3-cyanamider med formlen Ile med alkylen-diaminer eller disses monosalte udføres fortrinsvis ved temperaturer mellem 50 og 200°C, især 100 25 til 150°C, i nær- eller fraværelse af et opløsningsmiddel.The reaction of thienyl-3-cyanamides of formula Ile with alkylene diamines or their mono salts is preferably carried out at temperatures between 50 and 200 ° C, especially 100 25 to 150 ° C, in the presence or absence of a solvent.

Derved er det fordelagtigt at arbejde med et overskud af alkylendiamin eller dennes salte og at vælge opløsningsmidlet således, at omsætningen kan finde sted i homogen fase. Som opløsningsmiddel kommer højere alkoholer, f.eks.Thus, it is advantageous to work with an excess of alkylenediamine or its salts and to select the solvent so that the reaction can take place in a homogeneous phase. As the solvent comes higher alcohols, e.g.

30 butanol, amylalkohol eller hexanol på tale. Egnede salte af alkylendiaminer er f.eks. monohydroiodider eller mono-p--toluen-sulfonater. Thienyl-3-cyanamiderne kan fremstilles ud fra de tilsvarende thienyl-3-thiourinstoffer og kobbersulfat i alkalisk opløsning.30 butanol, amyl alcohol or hexanol in speech. Suitable salts of alkylenediamines are e.g. monohydroiodides or mono-β - toluene sulfonates. The thienyl-3-cyanamides can be prepared from the corresponding thienyl-3-thioureas and copper sulfate in alkaline solution.

35 b) N—(3'-thienyl)-N'—(aminoalkyl)—(thio)urinstof ferne med formel IV, der tjener som udgangsprodukter til fremgangsmåden ifølge b), fremstilles analogt med forskriften i Journal of Organic Chemistry 24:, 818 (1959) ved omsætning af de tilsvarende substituerede thienyl-3-isocyanater eller 5B) The N- (3'-thienyl) -N '- (aminoalkyl) - (thio) urea of formula IV, which serve as starting products for the process of b), is prepared by analogy to the Journal of Organic Chemistry 24: 818 (1959) by reacting the corresponding substituted thienyl-3-isocyanates or 5

OISLAND

1A6D36 isothiocyanater med alkylendiaminer med formel III. Ringslutningen foregår så ved opvarmning til temperaturer mellem 150 og 200°C i nær- eller fraværelse af et opløsningsmiddel, derved arbejdes fortrinsvis under anvendelse 5 af en beskyttelsesgasatmosfære, f.eks. nitrogen.1A6D36 isothiocyanates with alkylene diamines of formula III. The ring closure is then carried out by heating to temperatures between 150 and 200 ° C in the presence or absence of a solvent, thereby preferably being operated using a protective gas atmosphere, e.g. nitrogen.

c) Omsætningen af 3-amino-thiophener med formel V med 2-alkylmercapto-l,3-diazacyclopentener med formel VI kan ligeledes gennemføres i nær- eller fraværelse af et opløsningsmiddel. Der må dog vælges en tilstrækkelig høj tempe- lo ratur til fjernelse af alkylmercaptanen fra reaktionsblan dingen. I almindelighed arbejdes der ved temperaturer mellem 70 og 200°C. Som opløsningsmiddel kommer følgende i betragtning: højere kogende ethere, alkoholer, såsom methanol, ethanol og propanol, mættede cycliske carbonhydrider, såsom 15 cyclohexan og methylcyclohexan, aromatiske carbonhydrider, såsom benzen, toluen og xylen, chlorerede carbonhydrider, såsom chlor- og dichlorbenzen.c) The reaction of 3-amino-thiophenes of formula V with 2-alkylmercapto-1,3-diazacyclopentenes of formula VI can also be carried out in the presence or absence of a solvent. However, a sufficiently high temperature must be chosen to remove the alkyl mercaptan from the reaction mixture. In general, temperatures are between 70 and 200 ° C. As the solvent, the following are considered: higher boiling ethers, alcohols such as methanol, ethanol and propanol, saturated cyclic hydrocarbons such as cyclohexane and methylcyclohexane, aromatic hydrocarbons such as benzene, toluene and xylene, chlorinated hydrocarbons such as chloro and dichlorobenzene.

De nødvendige alkylmercapto-l,3-diazacyclopen-tener med den almene formel VI, som anvendes i form af 20 disses salte, f.eks. i form af hydroiodider, kan på kendt måde fremstilles ved alkylering af de tilsvarende alkylen-thiourinstoffer ifølge Organic Syntheses III, side 394.The required alkyl mercapto-1,3-diazacyclopenzenes of the general formula VI used in the form of their salts, e.g. in the form of hydroiodides, can be prepared in the known manner by alkylation of the corresponding alkylene thioureas according to Organic Syntheses III, page 394.

d) En yderligere fremgangsmåde til tilvejebringelse af forbindelserne med den almene formel I består i opvarmning 25 af bis-(2-oxo-l,3-diazacyclopentyl)-phosphinchlorider med formel VII med aminothiophener med formel V i et indifferent organisk opløsningsmiddel, f.eks. xylen eller mesitylen, til temperaturer mellem ca. 100 og 180°C. Udgangsstofferne med formel VII kan på kendt måde tilvejebringes ved omsætning 30 af de tilsvarende substituerede 1,3-diazacyclopentanoner-(2) med phosphorpentachlorid i chloroform ved temperaturer mellem 20 og 40°C (jf. Bull. Soc. Chim. France, 1961, side 2114).d) A further process for providing the compounds of general formula I consists in heating 25 bis (2-oxo-1,3-diazacyclopentyl) phosphine chlorides of formula VII with aminothiophenes of formula V in an inert organic solvent, f. eg. xylene or mesitylene, for temperatures between ca. 100 and 180 ° C. The starting materials of formula VII can be obtained in known manner by reacting 30 of the corresponding substituted 1,3-diazacyclopentanones- (2) with phosphorus pentachloride in chloroform at temperatures between 20 and 40 ° C (cf. Bull. Soc. Chim. France, 1961, page 2114).

e) Thiophen-3-isocyanid-dihalogenider med formlen VIII egner sig også til fremstilling af de omhandlede for-e) Thiophene-3-isocyanide dihalides of formula VIII are also suitable for the preparation of the present invention.

35 bindeiser. Omsætningen med alkylendiaminerne med formel III35 binders. The reaction with the alkylene diamines of formula III

foregår derved bedst i et organisk opløsningsmiddel ved temperaturer mellem Q'-'C og kogepunktet af det anvendte opløsningsmiddel. Som opløsningsmiddel kan der anvendes: dioxan, alkoholer, f.eks. methanol, ethanol, propanol eller butanol, ketoner, aromatiske carbonhydrider, f.eks. benzen, 6 0 144035 toluen, xylen og halogenerede aliphatiske eller aromatiske carbonhydrider. Ved denne reaktion opstår der 2 mol hydrogen-halogenid pr. mol isocyanid-dihalogenid. Dette hydrogenhaloge-nid kan enten bindes af overskydende alkylendiamin, af kalium-5 -eller natriumcarbonat eller af tertiære.aminer, f.eks. trime- thylamin, triethylamin, tributylamin eller Ν,Ν-dimethylcyclo-hexylamin.thereby best takes place in an organic solvent at temperatures between Q '-' C and the boiling point of the solvent used. As solvent can be used: dioxane, alcohols, e.g. methanol, ethanol, propanol or butanol, ketones, aromatic hydrocarbons, e.g. benzene, toluene, xylene and halogenated aliphatic or aromatic hydrocarbons. In this reaction, 2 moles of hydrogen halide per ml are formed. mole of isocyanide dihalide. This hydrogen halide can be bonded either by excess alkylenediamine, by potassium 5 or sodium carbonate or by tertiary amines, e.g. trimethylamine, triethylamine, tributylamine or Ν, Ν-dimethylcyclohexylamine.

Endelig kan forbindelser med formel I, hvor mindst 12 3 en af substituenterne R , R eller R betyder hydrogen, 1 ?Finally, compounds of formula I wherein at least 12 of one of the substituents R, R or R may be hydrogen, can be 1?

10 halogeneres. Derved tilvejebringes forbindelser, hvor R , R10 halogenes. Thereby, compounds are provided wherein R, R

og/eller R betyder et eller flere halogenatomer. Som halo-generingsmiddel kommer herved elementært brom, chlor, sulfurylchlorid, N-chlorsuccinimid, bromsuccinimid, 1,3--dichlor-5,5-dimethyl-hydantoin og iodmonochlorid på tale.and / or R represents one or more halogen atoms. As a halogenating agent, elemental bromine, chlorine, sulfuryl chloride, N-chlorosuccinimide, bromosuccinimide, 1,3-dichloro-5,5-dimethylhydantoin and iodine monochloride are thus discussed.

15 Derved kan der alt efter halogeneringsmidlerne arbejdes i ether, methylenchlorid, chloroform, tetrachlormethan, carbondisulfid, iseddike, nitrobenzen, thionylchlorid og sulfurylchlorid ved temperaturer mellem 0°C og kogepunktet af det pågældende opløsningsmiddel, eventuelt under tilsæt-20 ning af katalysatorer, f.eks. aluminiumchlorid eller ferri- chlorid.Accordingly, depending on the halogenating agents, ether, methylene chloride, chloroform, tetrachloromethane, carbon disulfide, glacial acetic acid, nitrobenzene, thionyl chloride and sulfuryl chloride can be worked at temperatures between 0 ° C and the boiling point of the solvent, optionally under the addition of catalysts. eg. aluminum chloride or ferric chloride.

Forbindelserne med den almene formel I kan omdannes til de tilsvarende syreadditionssalte. Til saltdannelsen kommer uorganiske og organiske syrer i betragtning, f.eks. eddi-25 kesyre, mælkesyre, propionsyre, maleinsyre, fumarsyre, vin syre, citronsyre, acetursyre, ascorbinsyre, oxyethansulfonsyre, saltsyre og hydrogenbromidsyre.The compounds of general formula I can be converted to the corresponding acid addition salts. For salt formation, inorganic and organic acids are considered, e.g. acetic acid, lactic acid, propionic acid, maleic acid, fumaric acid, tartaric acid, citric acid, aceturic acid, ascorbic acid, oxyethanesulfonic acid, hydrochloric acid and hydrobromic acid.

De omhandlede forbindelser udgør såvel i fri form som i form af deres salte værdifulde terapeutiske stoffer 30 med interessante farmakologiske især blodtrykssænkende egenskaber. De lader sig forarbejde med de sædvanlige hjælpe--og bærestoffer til alle til farmaceutiske formål anvendte tilberednings former.The compounds of the present invention are both in free form and in the form of their salts valuable therapeutic agents 30 with interesting pharmacological, especially blood pressure lowering properties. They can be processed with the usual auxiliaries and carriers for all pharmaceutical forms used for pharmaceutical purposes.

Fra dansk patentskrift nr. 108.364 kendes nært 35 beslægtede phenylamino-l,3-diazacyclopentener-(2), der lige ledes har en blodtrykssænkende virkning. Forbindelserne fremstillet ifølge opfindelsen har imidlertid et mere fordelagtigt forhold mellem toxicitet og terapeutisk virkning end disse kendte forbindelser, som det fremgår af de nedenfor omtalte sammenligningsforsøg 1 og 2.From Danish Patent Specification No. 108,364, nearly 35 related phenylamino-1,3-diazacyclopentener- (2) is known, which is just as having a blood pressure lowering effect. However, the compounds of the invention have a more advantageous relationship between toxicity and therapeutic effect than these known compounds, as can be seen in Comparative Experiments 1 and 2, discussed below.

0 144035 70 144035 7

De følgende eksempler skal nærmere belyse fremgangsmåden ifølge opfindelsen:The following examples are intended to illustrate in detail the process of the invention:

Eksempel 1 5 a) 2-(Thienyl-31—amino)-1,3-diazacyclopenten-(2) 30,0 g 3'-thienyl-S-methyl*“lsothiouronium-hydroiodid (smeltepunkt 113-115°C), som fås ud fra N-3-thienyl-thio-urinstof (smeltepunkt 185-187°C) og methyliodid i absolut methanol, rystes i en autoklav med 10,8 ml ethylendiamin 10 og 125 ml methanol i 20 timer ved 100°C. Efter afkøling si destilleres methanolen i vakuum, remanensen opløses i fortyndet saltsyre, uopløselige bestanddele frafiltreres og den vandige, saltsure fase udrystes flere gange med methylen-chlorid. Derpå filtreres den vandige fase med kul og gøres 15 alkalisk med koncentreret natriumhydroxidopløsning under afkøling. Den udfældede base frafiltreres på et nutschfilter, tørres og omkrystalliseres af benzen (smeltepunkt 155-156°C).Example 1 a) 2- (Thienyl-31-amino) -1,3-diazacyclopentene (2) 30.0 g of 3'-thienyl-5-methyl * isothiouronium hydroiodide (mp 113-115 ° C), which is obtained from N-3-thienyl-thiourea (m.p. 185-187 ° C) and methyl iodide in absolute methanol, is shaken in an autoclave with 10.8 ml of ethylenediamine 10 and 125 ml of methanol for 20 hours at 100 ° C. After cooling, the methanol is distilled in vacuo, the residue is dissolved in dilute hydrochloric acid, the insoluble components are filtered off and the aqueous hydrochloric acid phase is shaken several times with methylene chloride. The aqueous phase is then filtered with charcoal and made alkaline with concentrated sodium hydroxide solution under cooling. The precipitated base is filtered off on a soot filter, dried and recrystallized from benzene (mp 155-156 ° C).

Ud fra den fri base fås med etherisk saltsyre hydrochloridet af 2-(3r-thienylamino)-l,3-diazacyclopenten-(2), som omkry-20 stalliseres af isopropanol/petroleumsether (smeltepunkt 187-188°C).From the free base is obtained with the ethereal hydrochloric acid the hydrochloride of 2- (3r-thienylamino) -1,3-diazacyclopentene- (2), which is crystallized by isopropanol / petroleum ether (mp 187-188 ° C).

På analog måde fås: b) 2-(4 '-Methylthienyl-3 '-amino)-1,3-diazacyclopenten- (2) (smeltepunkt 156-158°C); hydrochlorid (smeltepunkt 200-202°C). 25 c) 2-(4'-Methylthienyl-3'-amino)-l,3-diaza-4-methyl-cyclopen- ten-(2) (smeltepunkt 172-173°C); hydrochlorid (smeltepunkt 132-133°C).Analogously obtained: b) 2- (4 '-Methylthienyl-3' -amino) -1,3-diazacyclopentene- (2) (mp 156-158 ° C); hydrochloride (m.p. 200-202 ° C). C) 2- (4'-Methylthienyl-3'-amino) -1,3-diaza-4-methyl-cyclopentene- (2) (mp 172-173 ° C); hydrochloride (mp 132-133 ° C).

d) 2-(4'-Chlorthienyl-3'-amino)-1,3-diazacyclopenten-(2) (smeltepunkt 174-175°C); hydrochlorid (smeltepunkt 205°C).d) 2- (4'-Chloro-thienyl-3'-amino) -1,3-diazacyclopenten- (2) (mp 174-175 ° C); hydrochloride (m.p. 205 ° C).

30 e) 2-(2',4'-Dimethylthienyl-3'-amino)-1,3-diazacyclopenten-(2), smeltepunkt for hydrochloridet 210-215°C (sønderdeling).E) 2- (2 ', 4'-Dimethylthienyl-3'-amino) -1,3-diazacyclopenten- (2), melting point of the hydrochloride 210-215 ° C (decomposition).

f) 2-(2',4'-Dichlorthienyl-3'-amino)-l,3-diazacyclopenten-(2), destruktionspunkt for hydrochloridet fra 295°C.f) 2- (2 ', 4'-Dichlorothienyl-3'-amino) -1,3-diazacyclopenten- (2), point of destruction of the hydrochloride from 295 ° C.

g) 2-(2'-Chlor-4'-methyl-thienyl-3'-amino)-l,3-diazacyclopenten-g) 2- (2'-Chloro-4'-methyl-thienyl-3'-amino) -1,3-diazacyclopentene

35 -(2) (smeltepunkt 152°C); hydrochlorid (smeltepunkt 228-229°C)L35 - (2) (mp 152 ° C); hydrochloride (mp 228-229 ° C) L

h) 2-(2'-Chlor-4'-methylthienyl-3'-amino)-1,3-diaza-4-methyl-cyclopenten-(2); hydrochlorid smeltepunkt 168-169°C.h) 2- (2'-Chloro-4'-methylthienyl-3'-amino) -1,3-diaza-4-methyl-cyclopenten- (2); hydrochloride melting point 168-169 ° C.

0 8 146035 i) 2-(21,5'-Dichlor-4'-methylthienyl-3'-amino)-l,3-diaza-cyclopenten-(2); hydrochloric! smeltepunkt 167-168°C. k) 2-(2'-Chlorthienyl-3'-amino)-1,3-diazacyclopenten-(2); hydrochlorid smeltepunkt 181-182°C.I) 2- (21,5'-Dichloro-4'-methylthienyl-3'-amino) -1,3-diaza-cyclopenten- (2); hydrochloric! mp 167-168 ° C. k) 2- (2'-Chloro-thienyl-3'-amino) -1,3-diazacyclopenten- (2); hydrochloride melting point 181-182 ° C.

5 1) 2-(2'-Iod-4'-methylthienyl-3'-amino)-1,3-diazacyclopenten- -(2)j hydrochlorid smeltepunkt 215-216°C. m) 2-(2',5'-Diiod-4'-methylthienyl-3’-amino)-1,3-diazacyclopenten- (2); hydrochlorid smeltepunkt 204-205°C.1) 2- (2'-Iodine-4'-methylthienyl-3'-amino) -1,3-diazacyclopenten- (2) hydrochloride mp 215-216 ° C. m) 2- (2 ', 5'-Diiodo-4'-methylthienyl-3'-amino) -1,3-diazacyclopenten- (2); hydrochloride melting point 204-205 ° C.

10 Eksempel 2 2-(4'-Methylthienyl-3'-amino)-l,3-diaza-4-methyl--cyclopenten-(2) 31,1 g 4'-methylthienyl-3'-S-methyl-isothiouronium--hydroiodid (smeltepunkt 119-120°C), som fås ud fra 4-methyl-15 thienyl-3-thiourinstof (smeltepunkt 158-159°C) og methyliodid i absolut methanol, opvarmes i en time til 130-150°C sammen med 8,2 g 1,2-diaminopropan. Derved iagttages en kraftig udvikling af methylmercaptan. Efter afkøling behandles remanensen med fortyndet saltsyre, den filtreres fra uopløselige be-20 standdele, og den sure opløsning udrystes flere gange med methylenchlorid og filtreres med kul. Derpå gøres opløsningen alkalisk med koncentreret natriumhydroxidopløsning under isafkøling. Den udfældede base frasuges, vaskes med lidt isvand, tørres og omkrystalliseres af isopropanol (smeltepunkt 25 173-174°C). Hydrochloridet kan fås ud fra basen med etherisk saltsyre og smelter ved 132-133°C (af isopropanol/petroleums-ether).Example 2 2- (4'-Methylthienyl-3'-amino) -1,3-diaza-4-methyl-cyclopenten- (2) 31.1 g of 4'-methylthienyl-3'-S-methyl-isothiouronium - hydroiodide (m.p. 119-120 ° C) obtained from 4-methyl-15-thienyl-3-thiourea (m.p. 158-159 ° C) and methyl iodide in absolute methanol is heated to 130-150 ° C for one hour. together with 8.2 g of 1,2-diaminopropane. Thereby a strong development of methyl mercaptan is observed. After cooling, the residue is treated with dilute hydrochloric acid, filtered from insoluble constituents and the acidic solution is shaken several times with methylene chloride and filtered with charcoal. The solution is then made alkaline with concentrated sodium hydroxide solution under ice-cooling. The precipitated base is suctioned off, washed with a little ice water, dried and recrystallized from isopropanol (mp 25 173-174 ° C). The hydrochloride can be obtained from the base with ethereal hydrochloric acid and melts at 132-133 ° C (of isopropanol / petroleum ether).

Eksempel 3 30 a) 2-(2',5'-Dibrom-4'-methylthienyl-3’-amino)-1,3- -diazacyclopenten-(2) 1,8 g 2-(4'-methylthienyl-3'-amino)-1,3-diazacyclopenten- (2) opløses i 15 ml iseddike, hertil sættes dråbevis under omrøring ved stuetemperatur en opløsning af 1,02 ml brom 35 i 15 ml iseddike. Derpå omrøres i endnu 20 minutter, suspen sionen hældes i 50 ml isvand, og den fremkomne opløsning gøres alkalisk under isafkøling. Den udfældede base frasuges, vaskes med isvand, tørres og overføres til hydrochloridet med etherisk saltsyre. Efter omkrystallisation af isopropanol/ether smelter 0 144035 9 den fremkomne 2—(2',5'-dibrom-4'-methylthieny1-3'-amino)-1,3--diazacyclopenten-(2) ved 224-225°C.Example 3 a) 2- (2 ', 5'-Dibromo-4'-methylthienyl-3'-amino) -1,3- -diazacyclopenten- (2) 1.8 g 2- (4'-methylthienyl-3 (-amino) -1,3-diazacyclopentene (2) is dissolved in 15 ml of glacial acetic acid, to which is added dropwise, at room temperature, a solution of 1.02 ml of bromine 35 in 15 ml of glacial acetic acid. The mixture is stirred for another 20 minutes, the suspension is poured into 50 ml of ice water and the resulting solution is made alkaline under ice-cooling. The precipitated base is suctioned off, washed with ice water, dried and transferred to the hydrochloride with ethereal hydrochloric acid. After recrystallization from isopropanol / ether, the resulting 2- (2 ', 5'-dibromo-4'-methylthienyl-3'-amino) -1,3-diazacyclopentene (2) melts at 224-225 ° C. .

Eksempel 4 5 a) 2-(2'-Chlor-4'-methylthienyl-3'-amino)-1,3- -diazacyclopenten-(2)_ 10 g 2-(4'-methylthienyl-3'-amino)-1,3-diazacyclopen-ten-(2) opløses i 125 ml chloroform og tilsættes dråbevis ved 0°C en opløsning af 7,5 ml sulfurylchlorid i 15 ral 10 chloroform. Derpå opvarmes til kogning i 2 timer, og efter afkøling afdestilleres chloroform og overskydende sulfurylchlorid i vakuum. Remanensen opløses i fortyndet saltsyre, den saltsure fase udrystes flere gange med methylenchlorid og filtreres derpå over kul. Den sure opløsning gøres basisk 15 med 6 N natriumhydroxidopløsning under isafkøling, og basen ekstraheres straks med methylenchlorid. Methylenchloridlaget tørres, opløsningsmidlet afdestilleres i vakuum, remanensen opløses i megen ether, og hydrochloridet udfældes med etherisk saltsyre. Hydrochloridet omkrystalliseres af isopropanol/petro-20 leumsether og smelter ved 228-229°C. Smeltepunktet af den frie base er 152°C (af methylcyclohexan/benzen).Example 4 a) 2- (2'-Chloro-4'-methylthienyl-3'-amino) -1,3- -diazacyclopenten- (2) 10 g of 2- (4'-methylthienyl-3'-amino) Dissolve -1,3-diazacyclopentene (2) in 125 ml of chloroform and add dropwise at 0 ° C a solution of 7.5 ml of sulfuryl chloride in 15 ml of chloroform. Then heat to boiling for 2 hours and after cooling, chloroform and excess sulfuryl chloride are distilled off in vacuo. The residue is dissolved in dilute hydrochloric acid, the hydrochloric acid phase is shaken several times with methylene chloride and then filtered over charcoal. The acidic solution is made basic with 6N sodium hydroxide solution under ice-cooling and the base is immediately extracted with methylene chloride. The methylene chloride layer is dried, the solvent is distilled off in vacuo, the residue is dissolved in much ether and the hydrochloride is precipitated with ethereal hydrochloric acid. The hydrochloride is recrystallized from isopropanol / petroleum ether and melts at 228-229 ° C. The melting point of the free base is 152 ° C (of methylcyclohexane / benzene).

Analogt fås:Analogously available:

b) 2-(2',4'-Dichlorthienyl-3'-amino)-1,3-diazacyclopenten-(2), destruktionspunkt for hydrochloridet fra 295°Cb) 2- (2 ', 4'-Dichloro-thienyl-3'-amino) -1,3-diazacyclopenten- (2), point of destruction of the hydrochloride from 295 ° C

25 c) 2-(2,-Chlor-4,-methylthienyl-3'-amino)-l,3-diaza-4-methyl- cyclopenten-(2); hydrochlorid smeltepunkt 168-169°C.C) 2- (2, -Chloro-4-methylthienyl-3'-amino) -1,3-diaza-4-methyl-cyclopenten- (2); hydrochloride melting point 168-169 ° C.

d) 2-(2,-Chlorthienyl-3'-amino)-l,3-diazacyclopenten-(2); hydrochlorid smeltepunkt 181-182°Cd) 2- (2, -Chlorothienyl-3'-amino) -1,3-diazacyclopenten- (2); hydrochloride melting point 181-182 ° C

U/,035 ίο oU /, 035 o o

Eksempel 5 a) 2—(21-lod-4'-methylthienyl-3'-amino)-1,3-di- azacyclopenten-(2)_ 1,8 g 2-(4'-methylthienyl-3'-amino)-l,3-diazacyclo-5 penten-(2) opløses i 30 ml iseddike og tildryppes ved stue temperatur en opløsning af 1,63 g iodmonochlorid i 17 ml iseddike. Derpå tilsættes 75 ml vand, og der opvarmes til 80°C i løbet af 20 minutter, og man lader opløsningen beholde denne temperatur, indtil iodfarven forsvinder. Efter afkøling 10 tilsættes aktivt kul, der filtreres og gøres alkalisk med natriumhydroxidopløsning under afkøling. Den faste remanens opløses i ether, gøres sur med etherisk saltsyre, opløsningsmidler frasuges, det faste stof koges med acetone, og der frasuges derpå. Hydrochloridet af 2-(2'-iod-4'-methylthienyl-15 -3'-amino)-1,3-diazacyclopenten-(2) omkrystalliseret af etha- nol/diisopropylether smelter ved 215-216°C.Example 5 a) 2- (21-Solo-4'-methylthienyl-3'-amino) -1,3-diazacyclopenten- (2) - 1.8 g of 2- (4'-methylthienyl-3'-amino) ) - 1,3-Diazacyclo-5-pentene- (2) is dissolved in 30 ml of glacial acetic acid and a solution of 1.63 g of iodine monochloride in 17 ml of glacial acetic acid is added dropwise at room temperature. Then 75 ml of water is added and heated to 80 ° C over 20 minutes and the solution is allowed to maintain this temperature until the iodine color disappears. After cooling 10, activated charcoal is filtered and made alkaline with sodium hydroxide solution under cooling. The solid residue is dissolved in ether, acidified with ethereal hydrochloric acid, the solvents are suctioned off, the solid is boiled with acetone and then suctioned off. The hydrochloride of 2- (2'-iodo-4'-methylthienyl-15 -3'-amino) -1,3-diazacyclopentene (2) recrystallized from ethanol / diisopropyl ether melts at 215-216 ° C.

b) På analog måde fås ved anvendelse af 3,25 g iodmonochlorid 2-(2',5'-dijod-4'-methylthienyl-3'-amino)-1,3-diazacyc-lopenten-(2) med et smeltepunkt på 142-146°C (smeltepunkt 20 af hydrochlorid 204-205°C).b) Analogously obtained using 3.25 g of iodine monochloride 2- (2 ', 5'-diiodo-4'-methylthienyl-3'-amino) -1,3-diazacyclopentene (2) with a melting point at 142-146 ° C (m.p. 20 of hydrochloride 204-205 ° C).

25 Eksempel 6 a) 2—(2',5'-Dichlor-4'-methylthienyl-3'-amino)--1,3-diazacyclopenten-(2) 5 g hydrochlorid af 2-(4'-methylthienyl-3'-amino)--1,3-diazacyclopenten-(2) suspenderes i 10 ml benzen og 30 tildryppes 5 ml sulfurylchlorid. Derpå opvarmes til kog ning i 2 timer, benzenen fradestilleres, remanensen koges med acetone og frasuges. Efter omkrystallisation af ethano 1/diisopropylether smelter hydrochloridet af 2— (2 ', 5' — -dichlor-4-methylthienyl-3'-amino)-1,3-diazacyclopenten-35 -(2) ved 167-168°C.Example 6 a) 2- (2 ', 5'-Dichloro-4'-methylthienyl-3'-amino) -1,3-diazacyclopenten- (2) 5 g hydrochloride of 2- (4'-methylthienyl-3 (-amino) - 1,3-diazacyclopentene- (2) is suspended in 10 ml of benzene and 5 ml of sulfuryl chloride are added dropwise. The mixture is then heated to boiling for 2 hours, the benzene is distilled off, the residue is boiled with acetone and extracted. After recrystallization from ethano 1 / diisopropyl ether, the hydrochloride of 2- (2 ', 5' - -dichloro-4-methylthienyl-3'-amino) -1,3-diazacyclopentene-35 - (2) melts at 167-168 ° C.

144035 11 o144035 11 o

Eksempel 7 2-(4'-methylthienyl-3'-amino)-1,3-diazacyclopenten- (2) 2,4 g 4-methylthienyl-3-guanidin (hydroøhlorid smeltepunkt 201-202°C) og 4 g ethylendiamin-mono-pT'toluen-5 sulfonat opvarmes til kogning i 25 ml ethanol i 48 timer.Example 7 2- (4'-methylthienyl-3'-amino) -1,3-diazacyclopenten- (2) 2.4 g of 4-methylthienyl-3-guanidine (hydrochloride mp 201-202 ° C) and 4 g of ethylenediamine The mono-pT'toluene sulfonate is heated to boiling in 25 ml of ethanol for 48 hours.

Opløsningsmidlet afdestilleres i vacuum, der sættes fortyndet natriumhydroxidopløsning til remanensen og ekstra-heres flere gange med methylenchlorid. Efter tørring med natriumsulfat frasuges opløsningsmidlet, og den faste re-10 manens frasuges efter at være blevet revet med ether. Fra den frie base fås med etherisk saltsyre hydrochloridet af 2-(41-methylthienyl-3 1-amino)-1,3-diazacyclopenten-(2), som smelter ved 200-202°C.The solvent is distilled off in vacuo, diluted sodium hydroxide solution is added to the residue and extracted several times with methylene chloride. After drying with sodium sulfate, the solvent is suctioned off and the solid residue is suctioned off after grating with ether. From the free base is obtained the ethereal hydrochloric acid hydrochloride of 2- (41-methylthienyl-3 1-amino) -1,3-diazacyclopenten- (2), which melts at 200-202 ° C.

15 Eksempel 8 2-(4'-methylthlenyl-3'-amino)-1,3-dlazacyclopenten-(2) 2,2 g N—(4-methylthienyl-3)—Ν'—(aminoethyl)—thio-urinstof (smeltepunkt 128-129°C) opløses i 25 ml ethanol, tilsættes 4 g bly-II-oxid og rystes i autoklav i 4 timer ved 20 100°C. Det fremkomne blysulfid frafiltreres, og ethanolen afdestilleres. Remanensen opløses i fortyndet saltsyre, filtreres med aktivt kul, og den sure opløsning gøres alkalisk med natriumhydroxidopløsning under afkøling. Den frie base frasuges og tørres. Smeltepunkt efter omkry-25 stallisation af isopropanol 156-158°C. Hydrochlorid smel tepunkt 200-202°C.Example 8 2- (4'-methylthlenyl-3'-amino) -1,3-dlazacyclopenten- (2) 2.2 g N- (4-methylthienyl-3) -Ν '- (aminoethyl) -thiourea (mp 128-129 ° C) is dissolved in 25 ml of ethanol, 4 g of lead II oxide is added and shaken in autoclave for 4 hours at 20 ° C. The resulting lead sulfide is filtered off and the ethanol is distilled off. The residue is dissolved in dilute hydrochloric acid, filtered with activated charcoal and the acidic solution made alkaline with sodium hydroxide solution under cooling. The free base is aspirated and dried. Melting point after recrystallization from isopropanol 156-158 ° C. Hydrochloride melting point 200-202 ° C.

Eksempel 9 2- (4 '-methylthienyl-3 '-amino) -1,3-diazacyclopen- 30 ten-(2) 2,6 g 4-methylthienyl-3-nitroguanidin (smeltepunkt 188-189°C) og 0,85 g ethylendiamin opvarmes til kogning i 50 ml ethanol i 24 timer. Efter afdestillation af opløsningsmidlet i vacuum, bringes den olieagtige remanens 35 til krystallisation med lidt vand og frasuges. Til fremstilling af hydrochloridet opløses basen i methylenchlorid, filtreres med aktivt kul og tilsættes etherisk saltsyre. Den efter afdampning af opløsningsmidlet fremkomne olieagtige remanens krystalliserer ved behandling med acetone. Smeltepunkt 200-202°C af isopropanol.Example 9 2- (4 '-methylthienyl-3' -amino) -1,3-diazacyclopentene (2) 2.6 g of 4-methylthienyl-3-nitroguanidine (mp 188-189 ° C) and 0 85 g of ethylenediamine are heated to boil in 50 ml of ethanol for 24 hours. After distilling off the solvent in vacuo, the oily residue 35 is crystallized with a little water and suctioned off. To prepare the hydrochloride, the base is dissolved in methylene chloride, filtered with activated carbon and ethereal hydrochloric acid added. The oily residue obtained after evaporation of the solvent crystallizes on acetone treatment. Melting point 200-202 ° C of isopropanol.

12 0 14403512 0 144035

Eksempel 10 2-(4'-methylthienyl-3'-amino)-1,3-diazacyclopen-ten-(2)_ 3,1 g mono-p-toluensulfonat af ethylendiamin op-5 løses i 20 ml amylalkohol. Til den kogende opløsning dryp pes en opløsning af 1 g 4-methyl-thienyl-3-cyanamid (smeltepunkt 97-98°C) i 20 ml amylalkohol, og der opvarmes til kogning i endnu 5 timer. Efter afkøling frafiltreres det uopløselige materiale, remanensen vaskes med ether, og 10 filtratet inddampes i vacuum. Remanensen opløses i fortyn det saltsyre, opløsningen filtreres med aktivt kul, og fra filtratet udfældes den frie base med natriumhydroxidopløsning under afkøling. Basen omkrystalliseres af isopropanol og smelter ved 156-168°C. Hydrochloridets smeltepunkt 15 200-202°C.Example 10 2- (4'-Methylthienyl-3'-amino) -1,3-diazacyclopentene (2) 3.1 g of mono-p-toluenesulfonate of ethylenediamine is dissolved in 20 ml of amyl alcohol. To the boiling solution, drizzle a solution of 1 g of 4-methyl-thienyl-3-cyanamide (mp 97-98 ° C) in 20 ml of amyl alcohol and heat to boiling for another 5 hours. After cooling, the insoluble material is filtered off, the residue is washed with ether and the filtrate is evaporated in vacuo. The residue is dissolved in dilute hydrochloric acid, the solution is filtered with activated charcoal and the free base is precipitated with sodium hydroxide solution under cooling. The base is recrystallized from isopropanol and melts at 156-168 ° C. The melting point of the hydrochloride is 200-202 ° C.

EksempelHEksempelH

2-(4'-Methylthienyl-3'-amino)-1,3-diazacyclopen-20 ten-(2)_ 1,8 g 4-Methyl-3-aminothiophen-hydrochlorid opvarmes sammen med 1,4 g 2-methyl-mercapto-l,3-diazacyc-lopenten(2) i 20 timer til 60-70°C. Derpå opløses blandingen i fortyndet saltsyre, filtreres med aktivt kul, og 25 filtratet indstilles basisk med 5 N natriumhydroxidopløs ning. Den udfældede base ekstraheres med methylenchlo-rid. Til yderligere rensning chromatograferes der på en aluminiumoxidsøjle. Der fås herved 2-(4'-methylthienyl--3'-amino)-l,3-diazacyclopenten-(2) med et smeltepunkt 30 på 156-158°C (fra isopropanol). Smeltepunkt af hydrochlo- ridet 200-202°C.2- (4'-Methylthienyl-3'-amino) -1,3-diazacyclopentene (2) - 1.8 g of 4-Methyl-3-aminothiophene hydrochloride is heated together with 1.4 g of 2-methyl -mercapto-1,3-diazacyclopentene (2) for 20 hours at 60-70 ° C. The mixture is then dissolved in dilute hydrochloric acid, filtered with activated charcoal and the filtrate is basified with 5N sodium hydroxide solution. The precipitated base is extracted with methylene chloride. For further purification, chromatograph on an alumina column. There is thus obtained 2- (4'-methylthienyl-3'-amino) -1,3-diazacyclopenten- (2) having a melting point of 156-158 ° C (from isopropanol). Melting point of hydrochloride 200-202 ° C.

Eksempel 12 2-(4'-Methylthienyl-3-amino)-1,3-diazacyclopenten-(2) 35 5,1 g Ν,Ν'-bis-(imidazolidinyl-2-on)~phosphoryl- chlorid emulgeres med 11,5 g 4-methyl-3-aminothiophen i 100 ml xylen under omrøring og opvarmes i 4 timer under tilbagesvaling. Efter afdestillering af opløsningsmidlet fjernes det resterende aminothiophen ved vanddampdestillation. Remanensen udrøres intensivt i 120 ml fortyndet 0 144035 13 saltsyre. Pra filtratet udfældes basen med 2 N natriumhydroxidopløsning og ekstraheres derefter med chloroform.Example 12 2- (4'-Methylthienyl-3-amino) -1,3-diazacyclopentene (2) 5.1 g of Ν, Ν'-bis (imidazolidinyl-2-one) ~ phosphoryl chloride is emulsified with 11 5 g of 4-methyl-3-aminothiophene in 100 ml of xylene with stirring and heated for 4 hours under reflux. After distilling off the solvent, the residual aminothiophene is removed by steam distillation. The residue is stirred intensively in 120 ml of dilute hydrochloric acid. From the filtrate, the base is precipitated with 2N sodium hydroxide solution and then extracted with chloroform.

Efter tørring af chloroformopløsningen afdampes opløsningsmidlet, og remanensen bringes til krystallisation ved 5 udrivning med ether. Efter frafiltrering af krystallerne omkrystalliseres disse fra methylcyclohexan og derpå om ønsket fra en smule isopropanol. Der fås 2-(4'-methylthie-nyl-3-amino)-l,3-diazacyclopenten-(2) med et smeltepunkt på 156-158°C. Hydrochloridet smelter ved 200-202°C.After drying the chloroform solution, the solvent is evaporated and the residue is crystallized by rinsing with ether. After filtration of the crystals, these are recrystallized from methylcyclohexane and then, if desired, from a little isopropanol. 2- (4'-methylthienyl-3-amino) -1,3-diazacyclopentene- (2) is obtained, mp 156-158 ° C. The hydrochloride melts at 200-202 ° C.

1010

Eksempel 13 2- (2',5'-Dichlorthienyl-3-amino)-1,3-diazacyclo- penten-(2)_ 13 g 4-Methyl-3-formylamino-thiophen sættes por-15 tionsvis under omrøring og afkøling med isvand til 50 ml frisk destilleret thionylchlorid, og der omrøres i 15 minutter. Derefter tilsættes der langsomt 36 ml sulfuryl-chlorid under omrøring og afkøling, idet opløsningens temperatur skal ligge under 5°C. Derpå omrøres reaktions-20 blandingen i 1 time ved 0°C, i 1 time ved stuetemperatur og i 5 timer ved 60°C. Reaktionsopløsningen inddampes derefter under formindsket tryk, og efter tilsætning af 150 ml toluen inddampes der endnu en gang. Den brune olieagtige remanens opløses i 100 ml toluen og afkøles til 0°C. Der-25 efter tilsættes der langsomt en opløsning af 5 g ethylen-diamin i 50 ml toluen under omrøring og afkøling. Derpå opvarmes reaktionsblandingen til stuetemperatur og omrøres derefter i 1 time ved 30°C. Efter afdestillering af toluenen under formindsket tryk udrøres remanensen i 30 100 ml 1 N saltsyre, og uopløst materiale frafiltreres.Example 13 2- (2 ', 5'-Dichloro-thienyl-3-amino) -1,3-diazacyclopenten- (2) 13 g of 4-Methyl-3-formylamino-thiophene is added portionwise with stirring and cooling. with ice water to 50 ml of freshly distilled thionyl chloride and stir for 15 minutes. Then, 36 ml of sulfuryl chloride is slowly added with stirring and cooling, the temperature of the solution being below 5 ° C. Then the reaction mixture is stirred for 1 hour at 0 ° C, for 1 hour at room temperature and for 5 hours at 60 ° C. The reaction solution is then evaporated under reduced pressure, and after the addition of 150 ml of toluene is evaporated again. The brown oily residue is dissolved in 100 ml of toluene and cooled to 0 ° C. Then, a solution of 5 g of ethylene diamine in 50 ml of toluene is slowly added with stirring and cooling. The reaction mixture is then warmed to room temperature and then stirred for 1 hour at 30 ° C. After distilling off the toluene under reduced pressure, the residue is stirred in 100 ml of 1 N hydrochloric acid and the undissolved material is filtered off.

Til den sure opløsning sættes derefter natriumhydroxidopløsning indtil basisk reaktion, og der ekstraheres nogle gange med methylenchlorid. Efter afdrivning af methy-lenchloridet opløses remanensen i 150 ml methanol og anbrin-35 ges på en silicagelsøjle. Produktet udvikles med en blanding af 300 ml methanol med koncentreret ammoniak i forholdet 9,5:0,5. Herved fås 2-(2',5'-dichlorthienyl-3-a-mino)-1,3-diazacyclopenten-(2). Hydrochloridet smelter ved 167-168°C.To the acidic solution is then added sodium hydroxide solution to basic reaction and sometimes extracted with methylene chloride. After evaporation of the methylene chloride, the residue is dissolved in 150 ml of methanol and placed on a silica gel column. The product is developed with a mixture of 300 ml of methanol with concentrated ammonia in the ratio of 9.5: 0.5. There is thus obtained 2- (2 ', 5'-dichloro-thienyl-3-a-mino) -1,3-diazacyclopenten- (2). The hydrochloride melts at 167-168 ° C.

14 0 14403514 0 144035

Den fordelagtige virkning af de her omhandlede forbindelser i forhold til forbindelsen Clonidin, der er . kendt fra dansk patentskrift nr. 108.364, fremgår af de i det følgende omtalte sammenligningsforsøg.The beneficial effect of the compounds of this invention over the compound Clonidine is. known from Danish Patent Specification No. 108,364, appears from the comparative experiments discussed below.

15 : 1*403515: 1 * 4035

u I Q) Ou I Q) O

0) -Η O M IW0) -Η O M IW

Sammenligningsforsøg 1. > ft ^ ® m tn _Q 0) T! 4-1 --1-i <1) Ji C fl iti m D> M to P d +J0) o o O J3 ,§ 3 f} ® Μ P <ncs oj æ 3 0 0 ή \ \ \ u - tu p d p S p or' o o α a <u (11 M-t <D «3 tt) 13 ____ A M p p d a -u d 3 ~ g I n o ω a> 'f -HP- (U 01 P A! 10 * * 5* “I £ · 0« -8 d 2 ^ S S \ «Ν ^ ~ i ^ 5 ? § I tr> ΙΟ p M ·ιβ 10 P £) p 0) P g S <J3 id φ Ό m (ΰΡ w * X tn σι μ A <u tuComparative Experiment 1.> ft ^ ® m tn _Q 0) T! 4-1 --1-i <1) Ji C fl iti m D> M to P d + J0) oo O J3, § 3 f} ® Μ P <ncs oj æ 3 0 0 ή \ \ \ u - tu pdp S p or 'oo α a <u (11 Mt <D «3 tt) 13 ____ AM ppda -ud 3 ~ g I no ω a>' f -HP- (U 01 PA! 10 * * 5 *“ I £ · 0 «-8 d 2 ^ SS \« Ν ^ ~ i ^ 5? § I tr> ΙΟ p M · ιβ 10 P £) p 0) P g S <J3 id φ Ό m (ΰΡ w * X tn σι μ A <u tu

« £ p S * 3, 2 * S > B1 S«£ p S * 3, 2 * S> B1 S

A O Φ P O O O M-ttifflfld 1 g p P nm m p co oi p p d> pA O Φ P O O O M-ttifflfld 1 g p P nm m p co oi p p d> p

O Φ P O A cn p iti PO Φ P O A cn p iti P

ro n· n u 0 10 0) Iti P 01 Pro n · n u 0 10 0) Iti P 01 P

—L!--v H-- 1 ....... ~ ' p » tn a: M—L! - v H-- 1 ....... ~ 'p »tn a: M

--;--B · C M ti « M-; - B · C M ti «M

I tn ns tu -s tn tnI tn ns tu -s tn tn

1 Ή · tji ti ti P1 Ή · tji ti ti P

Μ P p Γ-~ M - _ d CΜ P p Γ- ~ M - _ d C

O tti Φ o o o o \ 2 !5 P ii S1 2 ?}O tti Φ o o o o \ 2! 5 P ii S1 2?}

Spp * η Β-ο η« —-------- <U 01 W ~ (U Qj i p g p m d aSpp * η Β-ο η «—-------- <U 01 W ~ (U Qj i p g p m d a

Itn m d p P <u d Ai g p d p p a A p mItn m d p P <u d Ai g p d p p a A p m

p 11¾ 8» S> 2, g® 2 8 o 0 p o. Sp 11¾ 8 »S> 2, g® 2 8 o 0 p o .S

-X H ti S1 H1 >1 M P A -d 0 73 >i a > A ti ti ti tote do -Hd S-ι δ φ AAA O'd p p p M <U « li S m ΐ o p tn m o di m A 5 B Ί· -* N , ^ Λ 3 ^-XH ti S1 H1> 1 MPA -d 0 73> ia> A ti ti ti tote do -Hd S-ι δ φ AAA O'd ppp M <U «li S m ΐ on tn mo di m A 5 B Ί · - * N, ^ Λ 3 ^

O Φ Φ Ai <U P A P P PO Φ Φ Ai <U P A P P P

HCQUi >, A P 0) P P AHCQUi>, A P 0) P P A

Λ _______M a Ji H <u d _i in pihpmhuip» rS r a <ΰ <u d p tu a: mum O d iti · <U P ^Λ _______M a Ji H <u d _i in pihpmhuip »rS r a <ΰ <u d p tu a: mum O d iti · <U P ^

ΦΡ0 HDiNDitUdHHD0 HDiNDitUdH

ι-ifBP p c m tn G -η *-> Q. > d) Dl P O HIT! -HCpHItiP esι-ifBP p c m tn G -η * -> Q.> d) Dl P O HIT! -HCpHItiP es

si p p p n a· moo p m ® <U g Tsi p p p n a · moo p m ® <U g T

£ ® ‘tj £ i m d B $ § d:£ ® 'tj £ i m d B $ § d:

OTJ-p-H & d 0) P P ® M <UOTJ-p-H & d 0) P P ® M <U

P ti til Ά ,ρίηΰΑΡΑΡΡ •Η K------Μ Α Α -Η a Μ d nat. o3ddOdd5 A Η ,- m Ρ Ρ Ρ Ο Ρ <U Q.P ti to Ά, ρίηΰΑΡΑΡΡ • Η K ------ Μ Α Α -Η a Μ d night. o3ddOdd5 A Η, - m Ρ Ρ Ρ Ο Ρ <U Q.

gi JX I P σι ο (N fMD' p a J υ A --¾ p p g >~i — i+-t co co ic o·-! oitu· c tu u P U Φ P P P OJ H 01 > h O « A >t jjjj d'-'pgpa o P P-----1- P M A Dl 00 P Itigive JX IP σι ο (N fMD 'pa J υ A --¾ ppg> ~ i - i + -t co co ic o · -! oitu · c tu u PU Φ PPP OJ H 01> h O «A> t yyyy d '-' pgpa o P P ----- 1- PMA Dl 00 P Iti

Λ o h ODHOO tnS IS & 8 § 3 S t SΛ o h ODHOO tnS IS & 8 § 3 S t S

η ©. oho cno xiPojitBjtio p p PQ tp CNCNCN CN1 CM ti ϋ ΜΟΙΡ Αη ©. oho cno xiPojitBjtio p p PQ tp CNCNCN CN1 CM ti ϋ ΜΟΙΡ Α

H POMPQd IH POMPQd I

ppitituptuinro 2 itiPdA-na)* c ----a m d s p p Φ aipoiptuitiippitituptuinro 2 itiPdA-na) * c ---- a m d s p p Φ aipoiptuitii

M MtUXlitiA'POM MtUXlitiA'PO

1-1 P D< d1-1 P D <d

^ u A-&tUDi(Ud(UP^ u A- & tUDi {Out (UP

it <u js d d> p tn a Φ aupppdp^ É (OP otud-SADi pp io to ic in r- mpppp'SD' jj go σ m p p ®· p m rf!p ppppntn>, 2 <|P PtU>PBMd p o g <u 53 οι <uit <u js dd> p tn a Φ aupppdp ^ É (OP otud-SADi pp io to ic in r- mpppp'SD 'jj go σ mpp ® · pm rf! p ppppntn>, 2 <| P PtU> PBMd pog <u 53 οι <u

P -—---* M OldtUPdA PP -—--- * M OldtUPdA P

η p tuPAPaqaη p tuPAPaqa

u h tnAddPiudMu h tnAddPiudM

M O PDifflPtnin OM O PDifflPtnin O

. p iti (U Λ 01 P P. p iti (U Λ 01 P P

Μ &1+1 ^PdBMtUPΜ & 1 + 1 ^ PdBMtUP

0 (BMP Hmo pm pgaSSiup υ0 (BMP Hmo pm pgaSSiup υ

Ρ-ΡΧϋ DtUOOlMPPPΡ-ΡΧϋ DtUOOlMPPP

m gi λ xxx xx -S ΰ * 3 2 Vm gi λ xxx xx -S ΰ * 3 2 V

>-n λ C rt Λ h*4 ιΛζ Λ W ,p1 I> -n λ C rt Λ h * 4 ιΛζ Λ W, p1 I

C O' W &ppp®DiO ό P _______________— p tu p p tn p g A P iti A P Di ·· OPMOtUPintN (-» — P O Di P A P ® ' S pMOPdMDilC O 'W & ppp®DiO ό P _______________— p tu p p tn p g A P iti A P Di ·· OPMOtUPintN (- »- P O Di P A P ® S pMOPdMDil

to 01 P ·<β Iti tNto 01 P · <β Iti tN

01 I I I · »(eoipdflAA01 I I I · »(eoipdflAA

01 M HlPOl QiOMtDMIll p η Φ φέ,Χ£ MQoaio·^01 M HlPOl QiOMtDMIll p η Φ φέ, Χ £ MQoaio · ^

t ^ Ϊ T Mt ^ Ϊ T M

H p ΗΗΦ A ,H PMdPAH p ΗΗΦ A, H PMdPA

P >φ -ΗΡΡΦ P ^-115 Qj ιβΗΦΦΡ Ά PA J3pgig®>! P 0 Ad o +j a m g p h o -gy « «i “ ί s ° P Λ!Ρ ΟΦ-PSi P 2 Pd>nu PQ CXI &I0101P u H> -a M a > A L> 144035 16 0P> φ -ΗΡΡΦ P ^ -115 Qj ιβΗΦΦΡ Ά PA J3pgig®>! P 0 Ad o + j a m g p h o -gy «« i “ί s ° P Λ! Ρ ΟΦ-PSi P 2 Pd> now PQ CXI & I0101P u H> -a M a> A L> 144035 16 0

Sammenligningsforsøg 2.Comparative Experiment 2.

Hos rotter i Eviparr^narkose måles den blodtrykssænkende virkning efter injektion i sideventriklen i hjer-5 nen (J.F. Hayden, L.D. Johnson og R.P. Maickel, Life Sci ence 1509 (1966)).In rats in Eviparr anesthesia, the blood pressure lowering effect is measured after injection into the lateral ventricle of the brain (J.F. Hayden, L.D. Johnson and R.P. Maickel, Life Sciences 1509 (1966)).

Den blodtrykssaenkende virkning af forbindelsen fremstillet ifølge opfindelsen er omtrent lige så stor som den, der bevirkes af Clonidin. Den akutte toxicitet ]_q af Clonidin er imidlertid væsentlig større end den akut te toxicitet af forbindelsen fremstillet ifølge opfindelsen.The blood pressure lowering effect of the compound of the invention is about as great as that of Clonidin. However, the acute toxicity of Clonidine is substantially greater than the acute toxicity of the compound of the invention.

Tabel IITable II

15 -----15 -----

Toxx—Toxx-

Blodtrykssænkning hos rotter citetBlood pressure lowering in the rat site

Aktiv forbin- Dosis i pg Antall Blodtryk middelværdi DL^-g i-v., delse pr. dyr rotter —— --- rotter r a før efter differensActive compound Dose in pg Number of Blood Pressure Mean DL ^ -g i-v. animal rats —— —— rats are a before after difference

20 Forbindelse 2 2 127,5 120 7.5 5QCompound 2 2 127.5 120 7.5 5Q

fremstillet 4 2 127,5 91,5 31 mg/kg ifølge eks. 8 2 123,5 82,5 41 lf.prepared 4 2 127.5 91.5 31 mg / kg according to Example 8 2 123.5 82.5 41 lf.

2 5 130 113 17 29 25 Clonidin 4 5 128 105 23 mg/kg 8 5 135 105 302 5 130 113 17 29 25 Clonidine 4 5 128 105 23 mg / kg 8 5 135 105 30

Mus i.v.Mouse i.v.

3030

Forbindelse 1 1 155 100 55 40 fremstillet 2,5 1 120 58 72 mg/kg ifølge eks.Compound 1 1 155 100 55 40 prepared 2.5 1 120 58 72 mg / kg of Ex.

ie.ie.

Clonidin 1 1 132 85 47 17,6 mg/kg 35Clonidine 1 1 132 85 47 17.6 mg / kg 35

Claims (3)

1Λ A 03 Β 0 Patentkrav. Analogifremgangsmåde til fremstilling af 2-(thie-nyl-3'-amino)-1,3-diazacyclopentener-(2) med formlen 5 Λί-CHR41Λ A 03 Β 0 Patent claims. Analogous Process for Preparation of 2- (Thienyl-3'-Amino) -1,3-Diazacyclopentener- (2) of Formula 5 2 S R η-rNH-C ^NH-CEL· (I) 10 3 1 12 3 hvor R , R og R betyder hydrogen, methyl, chlor, brom 15 eller iod, og R4 betyder hydrogen eller methyl, eller sy readditionssalte deraf med fysiologisk acceptable syrer, kendetegnet ved, at a) thienyl-3-isothiuroniumsalte, -thiourinstof-fer, -guanidiner, -nitroguanidiner eller -cyanamider med 20 formel II, R2-,-p NH-R I (IX) 3 1 1 R R 25 hvor R betyder grupperne <NH , HX (a) SR5 -C (b) Xnh2 35 ^NH -C (c) Nsnh2 0 144035 >NH ~cf (cl) ^ΝΗΝ02 5 eller -CN (e) betyder lavmolekylært alkyl, og X betyder en syreanion, ]_q fortrinsvis en halogenidion, omsættes med alkylendiaminer med formel in H2N-CHR4-CH2-NH2 (III) 4 2_5 hvori R har ovennævnte betydning, eventuelt i form af disses monosalte, eller b) N-(3'-thienyl)-N'-aminoalkyl-(thio)urinstoffer med formel IV,2 SR η-rNH-C 2 NH-CEL · (I) 10 3 1 12 3 wherein R, R and R are hydrogen, methyl, chlorine, bromine or iodine, and R4 is hydrogen or methyl, or acid addition salts thereof with physiologically acceptable acids, characterized in that a) thienyl-3-isothiuronium salts, thioureas, guanidines, nitroguanidines or cyanamides of formula II, R2 -, - p NH-R I (IX) 3 1 1 RR Wherein R represents the groups <NH, HX (a) SR5 -C (b) Xnh2 35 ^ NH -C (c) Nsnh2 014 ~ 35 (NH) cf (cl) ^ ΝΗΝO2 and X is an acid anion, preferably a halide ion, reacted with alkylenediamines of formula in H2N-CHR4-CH2-NH2 (III) 4 wherein R is as defined above, optionally in the form of their monosalts, or b) N- (3) (-thienyl) -N'-aminoalkyl (thio) ureas of formula IV, 20 R2-,-—rNH-C-NH-CHR4-CH_-NH0 " * Δ (IV)R2 -, - rNH-C-NH-CHR4-CH_-NHO 3. A R -l JLr 25 hvor R^-R4 har ovennævnte betydning, og A betyder et oxy gen- eller svovlatom lukkes til ring, eller c) aminothiophener med formel V R2-]-pNH„ J Ιχ eVe 1 3 hvori R -R har ovennævnte betydning, omsættes med 2-al-25 kylmercapto-1,3-diazacyclopentener med formel VI3. AR-1 JLr 25 wherein R 1 -R 4 has the above meaning and A means an oxy gene or sulfur atom is closed to ring, or c) aminothiophenes of formula V R2 -] - pNH "J Ιχ eVe 1 3 wherein R - R is as defined above, reacted with 2-alkyl mercapto-1,3-diazacyclopentenes of formula VI
DK419670A 1969-08-16 1970-08-14 ANALOGY PROCEDURE FOR THE PREPARATION OF 2- (THIENYL-3'-AMINO) -1,3-DIAZACYCLOPENTENES DK144035C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1941761 1969-08-16
DE19691941761 DE1941761C3 (en) 1969-08-16 2- (Thienyl-3 '-amino) -1.3-diazacyclopentenes and process for their preparation

Publications (2)

Publication Number Publication Date
DK144035B true DK144035B (en) 1981-11-23
DK144035C DK144035C (en) 1982-04-26

Family

ID=5742998

Family Applications (1)

Application Number Title Priority Date Filing Date
DK419670A DK144035C (en) 1969-08-16 1970-08-14 ANALOGY PROCEDURE FOR THE PREPARATION OF 2- (THIENYL-3'-AMINO) -1,3-DIAZACYCLOPENTENES

Country Status (12)

Country Link
JP (1) JPS5416500B1 (en)
BR (1) BR6915362D0 (en)
DK (1) DK144035C (en)
ES (2) ES410035A1 (en)
FI (1) FI57412C (en)
IE (1) IE34428B1 (en)
IL (1) IL35093A (en)
NO (1) NO129573B (en)
PL (1) PL81180B1 (en)
SU (2) SU404244A3 (en)
YU (1) YU34295B (en)
ZA (1) ZA705543B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10224892A1 (en) * 2002-06-04 2003-12-18 Aventis Pharma Gmbh Substituted thiophenes, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them

Also Published As

Publication number Publication date
ES410035A1 (en) 1975-12-01
FI57412C (en) 1980-08-11
YU206970A (en) 1978-10-31
SU404244A3 (en) 1973-10-26
ES410034A1 (en) 1975-12-01
IE34428L (en) 1971-02-16
IE34428B1 (en) 1975-05-14
PL81180B1 (en) 1975-08-30
YU34295B (en) 1979-04-30
IL35093A0 (en) 1970-10-30
SU399126A3 (en) 1973-09-27
NO129573B (en) 1974-04-29
FI57412B (en) 1980-04-30
DK144035C (en) 1982-04-26
SU423297A3 (en) 1974-04-05
IL35093A (en) 1974-01-14
BR6915362D0 (en) 1973-01-04
JPS5416500B1 (en) 1979-06-22
ZA705543B (en) 1971-04-28

Similar Documents

Publication Publication Date Title
FI105182B (en) A process for the preparation of a therapeutically useful benzoylguanidine
US3758476A (en) 2-(thienyl-3&#39;-amino)-1,3-diazacycloalkenes
SE414402B (en) SET TO MAKE ALKYL-BENZIMIDAZOLE CARBAMATES
Razdan et al. A new class of antimalarial drugs: derivatives of benzothiopyrans
PT667341E (en) 4-AMINO-1-PEPERIDILBENZOYLGUANIDINES AS INHIBITORS OF THE ANTI-PROTEIN NA + / H +
WO2021056922A1 (en) Aryl sulfide containing benzylamine structure, synthesis method therefor and application thereof
CA1341314C (en) Derivatives of benzimidazole, benzothiazole and benzoxazole
GB1592272A (en) Fused thiazolidine derivatives and process for their manufacture
PL106947B1 (en) HOW TO MAKE NEW CARBONES SUBSTITUTED WITH 1-SULFONYLOBENZIMIDAZOLA
FI64144B (en) FREQUENCY REFRIGERATION FOR 2-ARYLAMINO-2-IMIDAZOLINE DERIVATIVES
US8183234B2 (en) Tricyclic guanidine derivatives as sodium-proton exchange inhibitors
DK144035B (en) ANALOGY PROCEDURE FOR PREPARING 2- (THIENYL-3-AMINO) -1,3-DIAZACYCLOPENTENES
HU193073B (en) Process for producing new benzimidazoles
JPS6254786B2 (en)
US7741320B2 (en) Cycloalkylated benzothiadiazines, a process for their preparation and pharmaceutical compositions containing them
PT87116B (en) PROCESS FOR THE PREPARATION OF NITROETENE DERIVATIVES
US3131218A (en) N-amino guanidine derivatives
CZ363798A3 (en) Anellated 5-membered cyclic compounds substituted by sulfonamide group, their use as medicaments and pharmaceutical composition containing thereof
FI110364B (en) Novel substituted sulfonamides and pharmaceutical compositions containing them
DK146016B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF SALICYLANILIDES
FI65996C (en) FORM OF THERAPEUTIC PREPARATION OF NUTRITIONAL N-2-FURYLMETHYL) -5-SULFAMOYL-ORTANYL SYROR OR DERAS SALTER
TW400320B (en) A benzoylguanidine compound having Na&lt;+&gt;/H&lt;+&gt; exchanger inhibitory activity, its preparation processes and the pharmaceutical compositions comprising the same
RU2547096C2 (en) N-[2-(adamant-2-yl)aminocarbonylmethyl]-n&#39;-(dialkylamino)alkylnitrobenzamides possessing antiarhythmic activity
FI62664B (en) FRAMEWORK FOR THE FRAMEWORK OF THERAPEUTIC ANVAENDBARA 6-PIPERAZINYL-11-METHYLENE-MORPHANTRIDINE DERIVATIVES
PT86964B (en) 1,10-PHENANTROLINES COMPOSITION FOR THE PREPARATION OF FUNGICIDE COMPOSITION

Legal Events

Date Code Title Description
PBP Patent lapsed